FindTrial
Sign In

using Ultrasound with High-Voltage Galvanic Current vs. Ultrasound with Medium-Frequency Current and recording Reduction in Pain and Improving Function in Mechanical Back Pain: A Randomized Trial

Efficacy of ultrasound combined with high-voltage galvanic current versus ultrasound with medium-frequency current in reducing pain and improving function in patients with mechanical back pain: a randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087754
Enrollment
66
Registered
2025-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M998- Other biomechanical lesions

Interventions

Intervention1: Ultrasound + High Voltage Pulsed Galvanic Current (HVPGC): Details: This group received therapeutic ultrasound along with HVPGC, which is a type of electrical stimulation using high-vol

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with mechanical back pain lasting between 4 and 12 weeks Not currently receiving other physical therapy modalities No history of significant spinal pathology, surgery, or contraindications to electrical stimulation or ultrasound therapy

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Patients with pacemakers or other implanted electrical devices Those with neurological disorders affecting balance or gait Patients with cognitive impairments that prevent informed consent

Design outcomes

Primary

MeasureTime frame
Reduction in pain intensity and improvement in functional mobility in patients with mechanical low back pain. Timepoint: Reduction in pain intensity and improvement in functional mobility in patients with mechanical low back pain.—

Secondary

MeasureTime frame
Reduction in disability scores (Oswestry Disability Index) Timepoint: Baseline, end of 2 weeks (post-intervention), and 4 weeks follow-up.—

Countries

India

Contacts

Public ContactKB Ranjeet Singh Chaudhary

Uttar Pradesh University Of Medical Sciences

chaudhary.ranjeet@rediffmail.com9760690454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026